Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
🌐 ES Home Catalog Education COAs Calculator Founder
Thymalin
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Immune › Thymalin
← Back to catalog ImmuneComing Soon

Thymalin (10 mg)

ThymicImmunityBioregulator
$105 USD10 mg/vial
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

Russian-developed thymic bioregulator extract — restores immune function in immunosenescent patients. Decades of clinical use in Russian geriatrics.

  • Mechanism: Thymic peptide complex (Khavinson) that regulates immune function; the zinc-thymulin axis underpins thymic health.
  • Evidence: Russian, preclinical and small-cohort research, not replicated.
  • In context: Profile poorly characterized outside the Russian literature.

Not in stock yet. Message us on WhatsApp and we'll let you know as soon as it arrives.

Rango de investigación · SC
5–10 mg per application · 2× per week
🔴 Research convention · SC convention (studied IM)

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundThymalin
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formula—
Molecular weightPolypeptide complex
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

Thymalin: research profile

Thymalin is a polypeptide complex extracted from calf thymus, developed by Vladimir Khavinson and Vyacheslav Morozov in Leningrad in the 1970s and registered in the USSR in 1982 as an immunomodulator. It is not a single peptide: it is a standardized fraction of low-molecular-weight peptides (1–10 kDa) defined by its extraction process, from which the synthetic dipeptide Thymogen (Glu-Trp) was later derived as an identifiable active principle. It is the founding product of the “peptide bioregulator” school.

Its proposed action is to restore thymic tissue function and, with it, the maturation and differentiation of T lymphocytes, normalizing the CD4/CD8 ratio and cytokine production in states of immunosenescence or immunosuppression. In animal models and in the original group's studies it improved cellular-immunity parameters in old animals and in radiation and chemotherapy models; the zinc–thymulin axis, central to thymic physiology, is often cited as the frame of reference.

Human evidence is extensive in number of publications but almost entirely Russian, from small cohorts and with methodological limitations; a Russian pilot trial in COVID-19 pneumonia exists from 2020. It holds no approval outside Russia and the Commonwealth of Independent States, and its animal origin implies lot-to-lot variability and biological-product considerations. Renova distributes it for research only.

Thymalin technical data

ClassBovine thymic polypeptide complex (biological product, bioregulator)
Composition1–10 kDa peptide fraction from calf thymus; no single sequence · synthetic derivative: Thymogen (Glu-Trp)
OriginKhavinson and Morozov, Leningrad, 1970s; Soviet registration 1982
Proposed actionRestoration of thymic function; T-lymphocyte maturation; CD4/CD8 normalization
ModelsAged animals, radiation, chemotherapy; small Russian human cohorts
Clinical routeIntramuscular in registered use; the SC route is a research convention
Regulatory statusRegistered only in Russia and the CIS; no FDA/EMA approval
NoteAnimal origin: lot-to-lot variability

Questions about Thymalin

Is Thymalin the same as thymosin alpha-1?

No. Thymalin is a bovine thymus extract, a peptide mixture with no single sequence and of Soviet origin; thymosin alpha-1 is a defined synthetic 28-amino-acid peptide with approval in more than thirty countries and international clinical trials. They share the organ of origin and the immune target, not identity or evidence base.

What is Thymogen and how is it related to Thymalin?

Thymogen is the dipeptide Glu-Trp that Khavinson's group identified as one of Thymalin's active components and synthesized as a defined molecule. It is the “simplified” version of the extract; Thymalin remains the complete fraction.

What clinical evidence supports Thymalin?

Numerous Russian publications since the 1980s in secondary immunodeficiencies, recurrent infections and elderly patients, generally small cohorts lacking the rigor of modern trials, plus a 2020 pilot in COVID-19. There are no independent controlled trials outside that setting.

Why is Thymalin considered a bioregulator?

Because it was the first product of the Khavinson school, which holds that short peptides derived from each organ regulate gene expression in that tissue. Thymogen, Epithalon (pineal), Pinealon (nervous) and others were later derived from Thymalin. The hypothesis has limited experimental support outside the original group.

Related reading: Thymosin Alpha-1: The Thymic Immunomodulating Peptide

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty